|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06667 MEGA GENOMICS
Nominal 
10.000 +2.260 (+29.199%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 107,291 | 8.507% | 151,300 | 145,727 | 237,185 | 203,220 |
| Cost of Sales | (37,673) | 12.189% | (63,004) | (64,004) | (70,509) | (56,979) |
| Gross Profit | 69,618 | 6.614% | 88,296 | 81,723 | 166,676 | 146,241 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 11,579 | (25,852) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (15,516) | (20,167) | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 43,042 | 1.749% | 36,179 | (21,418) | 95,882 | 94,903 | |
| Taxation | (6,073) | -15.477% | (6,141) | 3,800 | (16,867) | (15,806) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 36,969 | 5.274% | 30,038 | (17,618) | 79,015 | 79,097 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 284 | -- | 400 | (667) | 6,641 | 16,207 |
| Depreciation & Amortisation | 7,196 | -5.091% | 15,120 | 15,278 | 13,873 | 14,036 |
| Directors' Emoluments | -- | -- | 8,623 | 6,594 | 1,166 | 320 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 18.000 | 12.500% | 14.000 | -9.000 | 62.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.773 | (0.034) | 0.241 | -- |
| NBV per share ($) | 2.804 | -- | 2.709 | 2.583 | -- | -- |
| Remarks: | Real time quote last updated: 30/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 36,969,000 |
| %Change | 5.274% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 2.804 |